{"transactions":[{"id":2269880,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-05-16T20:04:38.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date."}],"balance_after":219954,"source":{"system":"sec-edgar","filing":"0001562180-22-004030","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022004030/primarydocument.xml","form_type":"4"}},{"id":2359627,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2022-03-03T02:12:30.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":70000,"derivative":{"exercise_price":2.16,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001562180-22-002164","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002164/primarydocument.xml","form_type":"4"}},{"id":2359626,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:30.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":40833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will become vested on the first anniversary of the grant date; and the remaining 2/3 of the Shares will vest in substantially equal quarterly installments thereafter, at the beginning of each of the following eight calendar quarters, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":69954,"source":{"system":"sec-edgar","filing":"0001562180-22-002164","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002164/primarydocument.xml","form_type":"4"}},{"id":2359625,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:30.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":3946,"price":2.1548,"value":8502.8408,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021."}],"balance_after":29121,"source":{"system":"sec-edgar","filing":"0001562180-22-002164","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002164/primarydocument.xml","form_type":"4"}},{"id":2442958,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:11:58.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":5833,"price":2.2862,"value":13335.4046,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on December 31, 2020."}],"balance_after":33067,"source":{"system":"sec-edgar","filing":"0001562180-22-000236","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022000236/primarydocument.xml","form_type":"4"}},{"id":2818965,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-03-02T21:06:33.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":44200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":44200,"derivative":{"exercise_price":3.46,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":44200},"source":{"system":"sec-edgar","filing":"0001562180-21-001774","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001774/primarydocument.xml","form_type":"4"}},{"id":2818964,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":127292,"kind":"person","name":"Cotreau Violetta","position":1,"cik":"0001841934","reported_name":"Cotreau Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:06:33.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":38900,"source":{"system":"sec-edgar","filing":"0001562180-21-001774","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001774/primarydocument.xml","form_type":"4"}}]}